Navigation Links
New therapy provides hope for millions of people suffering from bowel incontinence

CHICAGO- A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function. It is one of the only effective long-term treatments for bowel incontinence available to patients and Northwestern Memorial Hospital is one of the first medical centers in the country to offer the procedure.

"Bowel control problems can have a significant, detrimental effect on a person's emotional well-being," said Anne-Marie Boller, MD, a colon rectal surgeon at Northwestern Memorial. "Patients often struggle with everyday activities and withdraw from social interactions due to embarrassment or fear, causing them to suffer in silence. This treatment is a tremendous advancement that has the potential to improve patients' bowel control and their quality of life."

InterStim Therapy has been shown to reduce or eliminate bowel incontinence in 80 percent of patients according to recent studies. The treatment involves three steps: test stimulation, surgical implant and post-implant follow up. During the first phase, a thin wire is placed to stimulate the sacral nerve. This allows doctors to determine if the patient is likely to benefit from the therapy before moving forward with the full procedure. If the trial phase is successful, a long-term neurostimulator device, similar to a pacemaker, is then implanted in the buttock. The device has adjustable settings that can be tailored to the patient needs, and over time can be controlled by the patient using a programmer which works like a remote control. The final phase is follow-up monitoring.

"Until now, few treatments have been successful in treating bowel incontinence," said Amy Halverson, MD, a colon rectal surgeon at Northwestern Memorial. "This is an exciting new option that will give many patients their freedom back by eliminating symptoms. We are excited to be able to offer this to patients."

InterStim Therapy, previously available for treating symptoms of overactive bladder was recently approved by the U.S. Food and Drug Administration (FDA) for fecal incontinence. "We have been waiting for FDA approval for almost ten years for bowel control use, many of our patients had to seek treatment in other countries where the therapy was already approved," added Boller also an assistant professor of surgery in the division of gastrointestinal and oncologic surgery at Northwestern University Feinberg School of Medicine. To date, more than 85,000 people have received InterStim Therapy worldwide.

Physicians tout the ability to determine the probable success of the therapy before committing to the full procedure as one of the many benefits.

Fecal incontinence is most common in adults, predominately women, and is not a normal part of aging. The disorder can be caused by a variety of factors, including damage to the nerves or muscles in the anal canal and sphincter from trauma such as childbirth, or other pelvic health disorders.

"People should not be embarrassed and should not dismiss symptoms because they think it is a normal sign of getting older," said Halverson who is also an associate professor of surgery in the division of gastrointestinal and oncologic surgery at Feinberg School of Medicine. "Bowel incontinence may be unpleasant, but thanks to new therapies, you can stop symptoms and take back control of your life," said Boller.

Halverson and Boller are among the only physicians in the Chicago area offering this procedure. For more information, please visit the Northwestern Integrated Pelvic Health Program or call 312-926-0779.


Contact: Angela Salerno
Northwestern Memorial Hospital

Related medicine news :

1. Novel combined therapy extends life, diminishes pain in brain cancer patients
2. Virtual Reality May Help in Parkinsons Therapy
3. Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors
4. Special Talk Therapy Seems to Help Dying Patients
5. New Combo Therapy May Prevent TB, Save Lives in People With HIV
6. Experiment aboard shuttle Atlantis will test novel therapy to build bone during space travel
7. High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy
8. EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapy
9. New therapy for childhood neuroblastoma proves feasible and safe
10. Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients
11. Early Talk Therapy May Help Stroke Patients Bounce Back
Post Your Comments:
(Date:11/29/2015)... Raleigh, NC (PRWEB) , ... November 29, 2015 , ... ... calling on their colleagues to recognize the signs of mesothelioma and push for a ... the report on its website. Click here to read it now. ...
(Date:11/28/2015)... ... November 28, 2015 , ... StatRad ... has added Chris Hafey and Claude Hooton to its board of directors. The ... North America (RSNA) 2015 Annual Meeting and continues to strategically transform its focus ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Pixel Film ... customizable media panels to choose from, the possibilities are endless. Users have full control ... With the ProPanel: Pulse masking effects, users are sure to get heads to turn. ...
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, while ... light of the recent terrorist attacks in Paris, other cities are taking extra precautions ... reaching U.S. soil. Especially around special events that may be high-profile in nature, the ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Germany , Nov. 29, 2015 /PRNewswire/ ... Imaging invites attendees to experience the most complete mobile ... highlight on display is Ziehm Vision RFD 3D, the ... a 16 cm edge length per scan volume. In ... the first fully motorized mobile C-arm in four axes ...
(Date:11/27/2015)... 2015 Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... Une nouvelle approche consistant à combiner l,immunothérapie au ...    Clinical Cancer Research . ...
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
Breaking Medicine Technology: